Cypress Hill frontman and cannabis tycoon B-Real, AKA Louis Mario Freese, has expanded his Dr. Greenthumb’s Brand into Arizona. The move is a result of an exclusive partnership with the state’s premier curators of fine cannabis, The Flower Shop.
The strain offerings are exclusive to Dr. Greenthumb's Brand and available at The Flower Shop dispensaries in Phoenix, Ahwatukee, and Mesa before release statewide with additional collaborations and strain drops scheduled for early 2024.
The Dr. Greenthumb’s Brand flower line retails between $25 and $45 MSRP for 3.54g depending on the flower category.
“We are looking forward to a lasting relationship with The Flower Shop,” said B-Real. “Their entire group understands who we are and what we bring to the table and they’re equally committed to quality. I’ve been very impressed with their head of cultivation and the flower they produce, along with their mission of destigmatization and normalization of cannabis. And if I want to smoke it, we know we are onto something good!”
Dr. Greenthumb’s Arizona drops will maintain the same signature “three bags” categories the brand established in California, including:
- Loyalty, which includes the strains Peanut, Apple Turnover, Lemon Royale and Tahoe OG;
- Legacy, which includes Orange Monsoon, Jack Herer and Donny Burger; and
- Unapologetic, which includes Motor Breath, Gello and Soap.
The strains are grown at The Flower Shop’s 100,000-square-foot cultivation facility, The Flower Mine, which has played a major role in reviving the former Arizona mining town of San Manuel.
Experts believe cannabis stocks have found their floor and are now poised for unprecedented growth.
Join Benzinga PotProfits. Our in-house canna stock expert, Michael Berger, is on a mission to uncover the most promising cannabis stocks poised for growth, even in a dull market. He leaves no bud unturned to bring you the juiciest potential double-digit opportunities!
Just this year, the PotProfits portfolio has seen smoking-hot gains like:
- 47.10% with $GTBIF
- 40.23% with $TCNNF
- 21.50% with $VFF
Related News
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Click on the image for more info.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry?
Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.
Get your tickets now before prices surge by following this link.